chartexchange

ATYR
aTyr Pharma, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:52 PM EST
4.09USD-18.036%(-0.90)117,947
After-hoursNov 18, 2026 4:00:30 PM EST
4.08USD-0.245%(-0.01)
Loading…
Loading…
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
San Diego, California, USA
Previous Close
$4.99
Beta
8.82
52-Week High
$7.98 2026-11-10
52-Week Low
$0.10 2026-10-27
SMA 50
$2.10
SMA 200
$1.03
Avg. Vol 10D
83,675
Avg. Vol 30D
1.20M
Avg. Vol 90D
2.64M
Relative Vol
0.10
2.45M
2.1300%
10,678
ATYR Profile

atyr pharma (nasdaq: life) is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology, a newly discovered set of physiological modulators. the company's lead candidate, resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component. resolaris is currently in a phase 1b/2 clinical trial in adult patients with facioscapulohumeral muscular dystrophy (fshd); a phase 1b/2 trial in adult patients with limb girdle muscular dystrophy (lgmd) 2b or fshd; and a phase 1b/2 trial in patients with an early onset form of fshd. to protect this pipeline, atyr built an intellectual property estate comprising 70 issued or allowed patents and over 240 pending patent applications that are solely owned or exclusively licensed by atyr. atyr's key programs are currently focused on severe, rare diseases characterized by immune dysregulation

ATYR Performance
PeriodPriceDateChangeBeta
1W6.212026-11-12-34.14%1.896
1M0.172026-10-19+2282.06%56.871
3M0.532026-08-19+667.64%31.725
6M0.482026-05-19+746.79%15.030
1Y0.682025-11-19+505.75%8.820
2Y3.042024-11-19+34.54%—
5Y8.202021-11-19-50.12%1.835
ATYR Stock Summary

aTyr Pharma, Inc. Common Stock (NASDAQ:ATYR) stock price today is $4.09, and today's volume is 117,947. ATYR is down 18.036% today. The 30 day average volume is 1.20M. ATYR market cap is $10.43M with 2.55M shares outstanding.